Capstar 11.4mg for cats small dogs are tablets designed to combat flea infestations in cats and small dogs, containing nitenpyram as the active ingredient. This neonicotinoid inhibits the transmission of excitation, which in turn leads to the death of adult fleas. Capstar 11.4mg for cats small dogs at a glance tablets to combat flea infestations in cats and small dogs weighing 1 11 kg over the age of 4 weeks oral tablets with the active ingredients nitenpyram to support the treatment of flea infestations kills fleas ctenocephalides felis effects on fleas can be observed as early as 15 to 30 minutes after administration of the product to the host animal. These occur simultaneously with the fleas' first blood meal after sufficient blood levels have been reached in the host animal. 95 % to 100 % efficacy is observed within the first 6 hours. 100 % efficacy is achieved within 24 hours without residual activity further information use during pregnancy and lactation nitenpyram can be administered during pregnancy and lactation. Studies in laboratory animals rats and rabbits showed no signs of teratogenic or foetotoxic effects. The tolerability of the product has been demonstrated in pregnant and lactating cats and dogs contraindications according to the manufacturer, there are no known contraindications. Side effects pets may experience increased itching in the first hour after administering the capstar 11.4mg for cats small dogs. This effect is caused by the fleas reacting to the product. In very rare cases, your dog may experience temporary hyperactivity, panting, vocalisation and excessive grooming licking. Very rarely, transient neurological symptoms such as muscle tremors, ataxia and convulsions have been reported. The frequency of side effects is defined as follows very common more than 1 in 10 treated animals show side effects common more than 1 but less than 10 out of 100 treated animals occasional more than 1 but less than 10 out of 1000 treated animals rare more than 1 but less than 10 in 10,000 treated animals very rare less than 1 in 10,000 treated animals, including individual case reports the federal office of consumer protection and food safety, mauerstraße 39 42, 10117 berlin or the pharmaceutical company should be notified of any adverse reactions. Interactions with other medicinal products and other interactions none known. In clinical studies, no adverse drug reactions were observed with nitenpyram was used alongside other veterinary products, including other common flea products, anthelmintics, vaccines or antibiotics. For risks and side effects, please read the enclosed leaflet and consult your veterinarian or pharmacist. For further information on pharmaceutical products sold through our pharmacy, please contact us at e pharmacyzooplus.com. Marketing authorisation holder in germany elanco gmbh, heinz lohmann str. 4, d 27472 cuxhaven